Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sohm Inc
(OP:
SHMN
)
0.0007
-0.0001 (-12.50%)
Streaming Delayed Price
Updated: 9:33 AM EDT, May 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
800,000
Open
0.0007
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0008
Today's Range
0.0007 - 0.0007
52wk Range
0.0004 - 0.0016
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
SOHM, Inc., Unveils Genetically Engineered Ovarian Cancer Cell Line Using ABBIE(TM) Platform to Accelerate GYS1 Drug Discovery
May 06, 2025
Via
ACCESS Newswire
Dr. Leonardo Mirandola Joins SOHM, Inc. as an Advisory Board to Advance CAR-T Cell Projects Toward Clinical Trials and Commercialization
May 02, 2025
Via
ACCESS Newswire
Performance
YTD
N/A
N/A
1 Month
-12.5%
-12.5%
3 Month
-12.5%
-12.5%
6 Month
-36.4%
-36.4%
1 Year
-41.7%
-41.7%
More News
Read More
SOHM Inc. Awarded European Patent for Innovative ABBIE Genome Editing Technology
May 01, 2025
Via
ACCESS Newswire
SOHM, Inc. Agrees to Licensing for Investigational and Pre-Clinical Studies for Groundbreaking ABBIE Genome Editing Technology for CAR-T Cell Cancer Therapies
April 28, 2025
Via
ACCESS Newswire
SOHM, Inc. has Received ABBIE Technology Kits' Pre-Launch Pre-Orders
September 25, 2024
Via
ACCESSWIRE
Rheumatoid Arthritis Patients Face Heightened Risk of Depression, Study Finds
March 11, 2024
Via
Investor Brand Network
Why Prescription Drugs Can Be Costly
February 01, 2024
Via
Investor Brand Network
SOHM, Inc. Announces Patent Allowance/Approval in South Korea
April 16, 2025
Via
ACCESS Newswire
SOHM, Inc. Shares an Exciting Expansion and Upcoming Presentation on ABBIE
April 10, 2025
Via
ACCESS Newswire
SOHM, Inc. Launches New AI Team to Advance ABBIE System and Genome Editing Innovations
April 07, 2025
Via
ACCESS Newswire
SOHM, Inc. Shares Groundbreaking Findings in ABBIE Technology
March 10, 2025
Via
ACCESS Newswire
SOHM, Inc. Announce Dr. Wei Zhu Onboard as Senior Marketing and Sales Consultant
November 20, 2024
Via
ACCESSWIRE
SOHM, Inc. Announces Allowances Of Japanese Patent Claims Received from Japan's Patent Office (特許庁, Tokkyochō, JPO) Protecting Transformative SOHM-ABBIE Genome Edited, SAGE Recombinant-Organisms, -Cells, -Secretomes, -Exosomes
November 14, 2024
Via
ACCESSWIRE
SOHM, Inc. Announce Dr. David Zarling Onboard as Senior Product Development Advisor
October 22, 2024
Via
ACCESSWIRE
SOHM, Inc. Continues to Build its IP Portfolio in the Gene Editing and Cell Engineering Space
October 02, 2024
Via
ACCESSWIRE
SOHM, Inc., Announce Dr. Tetsuya Kawamura Ph. D. Joined as a Cell Engineer and Biochemist
August 02, 2024
Via
ACCESSWIRE
SOHM, Inc. has signed the Manufacturing and Supply of Skincare Topical Products with New Export Customers
July 30, 2024
Via
ACCESSWIRE
SOHM, Inc., Announce a New Collaboration and Joins Forces with Stanford University
July 25, 2024
Via
ACCESSWIRE
SOHM, Inc. Announces its ABBIE Genome Editing Technology Successfully Engineered a T-cell immunotherapy from a Healthy Human Donor
June 10, 2024
Via
ACCESSWIRE
BioMedNewsBreaks — SOHM, Inc. (SHMN) Continues to Advance Groundbreaking Technology
May 22, 2024
Via
Investor Brand Network
InvestorNewsBreaks – SOHM, Inc. (SHMN), Coastar Therapeutics Collaborate to Advance Field of Genome Editing
April 01, 2024
Via
Investor Brand Network
FDA Grants Florida Permission to Import More Affordable Medicines from Canada
February 21, 2024
Via
Investor Brand Network
Exposures
Product Safety
Small Study Shows Existing Drug Could Reduce Opioid Administration After Surgery
January 22, 2024
Via
Investor Brand Network
New Compound Promises Greater Efficacy Against Pain, Has No Side Effects
January 09, 2024
Via
Investor Brand Network
BioMedNewsBreaks– SOHM Inc. (SHMN) Announces Filing of Provisional Patent for ABBIE Smart Gene Editing Technology
January 09, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Frequently Asked Questions
Is Sohm Inc publicly traded?
Yes, Sohm Inc is publicly traded.
What exchange does Sohm Inc trade on?
Sohm Inc trades on the OTC Traded
What is the ticker symbol for Sohm Inc?
The ticker symbol for Sohm Inc is SHMN on the OTC Traded
What is the current price of Sohm Inc?
The current price of Sohm Inc is 0.0007
When was Sohm Inc last traded?
The last trade of Sohm Inc was at 05/08/25 09:33 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.